Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics
CJ Glueck, N Goldenberg - Metabolism, 2019 - Elsevier
Polycystic ovary syndrome (PCOS) has multiple etiologies including ovarian and adrenal
hyperandrogenism, neuro-endocrine and hypothalamic-pituitary dysfunction, and disorders …
hyperandrogenism, neuro-endocrine and hypothalamic-pituitary dysfunction, and disorders …
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen …
RA Wild, E Carmina… - The Journal of …, 2010 - academic.oup.com
Objective: Women with polycystic ovary syndrome (PCOS) often have cardiovascular
disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE …
disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE …
Effectiveness of primary care–relevant treatments for obesity in adults: a systematic evidence review for the US Preventive Services Task Force
ES LeBlanc, E O'Connor, EP Whitlock… - Annals of internal …, 2011 - acpjournals.org
Background: Overweight and obesity in adults are common and adversely affect health.
Purpose: To summarize effectiveness and harms of primary care–relevant weight-loss …
Purpose: To summarize effectiveness and harms of primary care–relevant weight-loss …
Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Background Polycystic ovary syndrome (PCOS) is characterised by infrequent or absent
ovulation, and high levels of androgens and insulin (hyperinsulinaemia). Hyperinsulinaemia …
ovulation, and high levels of androgens and insulin (hyperinsulinaemia). Hyperinsulinaemia …
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review
Metformin is an insulin sensitizer widely used for the treatment of patients affected by type 2
diabetes mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin …
diabetes mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin …
Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
E Diamanti-Kandarakis, CD Christakou… - European journal of …, 2010 - academic.oup.com
Polycystic ovary syndrome (PCOS) is now recognized to be the most common
endocrinopathy in women of reproductive age with a prevalence of 6.6–6.8%. PCOS, a …
endocrinopathy in women of reproductive age with a prevalence of 6.6–6.8%. PCOS, a …
[PDF][PDF] Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.
S Gerli, E Papaleo, A Ferrari… - European Review for …, 2007 - europeanreview.org
Randomized, double blind placebo-controlled trial: effects of Myo-inositol on ovarian
function and metabolic factors in women wi recorded. There was an inverse relationship …
function and metabolic factors in women wi recorded. There was an inverse relationship …
A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome
W Wei, H Zhao, A Wang, M Sui, K Liang… - European journal of …, 2012 - academic.oup.com
Objective Polycystic ovary syndrome (PCOS) is a frequent reproductive and metabolic
disorder associated with insulin resistance (IR). Berberine (BBR) is an isoquinoline …
disorder associated with insulin resistance (IR). Berberine (BBR) is an isoquinoline …
Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based …
Abstract Background Polycystic Ovary Syndrome (PCOS) is an endocrine disorder that
affects women in reproductive age and represents an unfavourable risk factor for several …
affects women in reproductive age and represents an unfavourable risk factor for several …
The role of obesity in the development of polycystic ovary syndrome
A Beatriz Motta - Current pharmaceutical design, 2012 - ingentaconnect.com
Polycystic Ovary Syndrome (PCOS) is one of the common endocrine diseases that affects
women in their reproductive age. PCOS has diverse clinical implications that include …
women in their reproductive age. PCOS has diverse clinical implications that include …